PRIMA1 and neoplasm: In addition, the anti-tumor effects of PRIMA-1 and APR-246 appeared mediated by changes in cell cycle progression, with an accumulation of cells in the G0/G1 phase [19,24,27,46,48,49,50,54,60], or in the G2 phase [8,20,26,32,48].